📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
51%
💰 Capital Raise
55%
• Critical: only 0.1 months cash remaining
📉 Score Deterioration
50%
• Score rose 41 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔄 Reverse Split
45%
• 50-day avg $1.34 approaching $1 threshold
• Only 0 months cash — financial pressure
💹 Market Data
Market Cap$86.61M
Shares Outstanding60.85M
FloatN/A
Cash$185.9K
Debt$2.26M
Short InterestN/A
🏛 Institutional Holdings
0.1% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest71.0K
Days to Cover7.5
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for GIBO
📊 GIBO FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GIBO Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.